Table 1

Secondary outcomes measured and inclusion in EMU-Audit and/or EMU-Cohort

OutcomeOutcome measuresEMU-AuditEMU-Cohort
Clinical outcomes

  • Length of hospital±OPAT admission (days)

  • Mortality during admission for invasive infection

  • ICU admission requirement, length of stay (days), intubation requirement

  • Surgery requirement

  • Unplanned discharge from either inpatient or OPAT admission

  • Patient directed discharge

  • Personal threat codes for behaviours impacting care and/or formation of behavioural contract

  • Healthcare associated bloodstream infection

  • Treatment failure—worsening or ongoing infection resulting in prolonged therapy

✓✓
Patient-reported experience

  • Australian Hospital Patient Experience Question Set

✗✓
Readmission

  • Readmission for infection or treatment-related complications during OPAT/oral antimicrobial discharge period

  • Unplanned readmission for any reason in 30-day period following discharge for invasive infection

  • Readmission free survival 30 days postdischarge

  • Readmission free survival 90 days postdischarge

✗✓
Lost to follow-up

  • Participant unable to be contacted at 30-day or 90-day follow-up

✗✓

  • EMU, Epidemiology and Management of invasive infections among people who Use drugs; ICU, intensive care unit; OPAT, outpatient parenteral antimicrobial therapy.